Flavii Therapeutics raises €843,000 for neurological disease therapies

What's the deal? Flavii Therapeutics, a spin-off of the University of BarcelonaDealroom has a profile for this one. Try Dealroom →, has raised €843,000 to develop new therapies for central nervous system diseases. Grow Venture PartnersDealroom has a profile for this one. Try Dealroom → led the round, with participation from Institut Català de Finances and WA4STEAMDealroom has a profile for this one. Try Dealroom →.

What's the endgame? The Barcelona-based company is building treatments targeting neurological disorders. The new capital will advance its therapy development.

The signal: Early-stage biotech coming out of Spanish universities continues to draw backing from a mix of venture capital and public finance institutions, pointing to sustained appetite for research-driven neurological therapeutics.

Read more: elreferente.es

Image credit: jurvetson